These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 14574909)

  • 1. [Doxifluridine for treatment of colorectal cancer].
    Nishimura G; Miwa K
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():345-8. PubMed ID: 14574909
    [No Abstract]   [Full Text] [Related]  

  • 2. Penetration of capecitabine and its metabolites into malignant and healthy tissue of patients with advanced breast cancer.
    Mader RM; Schrolnberger C; Rizovski B; Brunner M; Wenzel C; Locker G; Eichler HG; Mueller M; Steger GG
    Int J Clin Pharmacol Ther; 2002 Dec; 40(12):571-2. PubMed ID: 12503818
    [No Abstract]   [Full Text] [Related]  

  • 3. The significance of thymidine phosphorylase expression in colorectal cancer.
    Katsumata K; Sumi T; Yamashita S; Takahashi S; Mori M; Baba T; Murohashi T; Nagashima K; Ashizawa T; Yamamoto K; Koyanagi Y; Katoh K
    Oncol Rep; 2001; 8(1):127-30. PubMed ID: 11115583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymidine phosphorylase (TP) activation: convenience through innovation.
    Van Cutsem E; Cunningham D; Hoff PM; Maroun J
    Oncologist; 2001; 6 Suppl 4():1-2. PubMed ID: 11585967
    [No Abstract]   [Full Text] [Related]  

  • 5. Thymidine phosphorylase and dihydropyrimidine dehydrogenase levels in primary colorectal cancer show a relationship to clinical effects of 5'-deoxy-5-fluorouridine as adjuvant chemotherapy.
    Nishimura G; Terada I; Kobayashi T; Ninomiya I; Kitagawa H; Fushida S; Fujimura T; Kayahara M; Shimizu K; Ohta T; Miwa K
    Oncol Rep; 2002; 9(3):479-82. PubMed ID: 11956613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymidine phosphorylase expression and effect of doxifluridine: a phase II study.
    Sadahiro S; Otani Y; Oya K; Ike H; Shimada H; Yamaguchi S; Hiki Y; Fujita H; Mitomi T
    Oncol Rep; 2001; 8(4):753-8. PubMed ID: 11410777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Capecitabine in the treatment of colorectal cancer].
    Zeuli M; Pino MS; Cognetti F
    Tumori; 2001; 87(1 Suppl 1):S55-6. PubMed ID: 11300027
    [No Abstract]   [Full Text] [Related]  

  • 8. Capecitabine in advanced gastric or oesophagogastric cancer: a viewpoint by Sai-Hong Ignatius Ou and Randall F. Holcombe.
    Ou SH; Holcombe RF
    Drugs; 2007; 67(4):611-2. PubMed ID: 17352521
    [No Abstract]   [Full Text] [Related]  

  • 9. In vivo monitoring of capecitabine metabolism in human liver by 19fluorine magnetic resonance spectroscopy at 1.5 and 3 Tesla field strength.
    van Laarhoven HW; Klomp DW; Kamm YJ; Punt CJ; Heerschap A
    Cancer Res; 2003 Nov; 63(22):7609-12. PubMed ID: 14633676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capecitabine in the treatment of colorectal cancer.
    O'Neill VJ; Cassidy J
    Future Oncol; 2005 Apr; 1(2):183-90. PubMed ID: 16555988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive markers of capecitabine sensitivity identified from the expression profile of pyrimidine nucleoside-metabolizing enzymes.
    Yasuno H; Kurasawa M; Yanagisawa M; Sato Y; Harada N; Mori K
    Oncol Rep; 2013 Feb; 29(2):451-8. PubMed ID: 23229803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capecitabine in colorectal, breast, and other solid tumors: novel therapeutic approaches. Selected abstracts from ASCO 2003.
    Oncology (Williston Park); 2003 Aug; 17(8 Suppl 8):10-62; quiz 63-4. PubMed ID: 14570064
    [No Abstract]   [Full Text] [Related]  

  • 13. Uridine phosphorylase in breast cancer: a new prognostic factor?
    Yan R; Wan L; Pizzorno G; Cao D
    Front Biosci; 2006 Sep; 11():2759-66. PubMed ID: 16720348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capecitabine: indications and future perspectives in the treatment of metastatic colorectal and breast cancer.
    Cassata A; Procoplo G; Alù M; Ferrari L; Ferrario E; Beretta E; Longarini R; Busto G; De Candis D; Bajetta E
    Tumori; 2001; 87(6):364-71. PubMed ID: 11989587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-line capecitabine is as effective as 5-fluorouracil/leucovorin in treating advanced colorectal cancer.
    Gambill BD
    Clin Colorectal Cancer; 2001 May; 1(1):18-9. PubMed ID: 12445375
    [No Abstract]   [Full Text] [Related]  

  • 16. Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients.
    Schüller J; Cassidy J; Dumont E; Roos B; Durston S; Banken L; Utoh M; Mori K; Weidekamm E; Reigner B
    Cancer Chemother Pharmacol; 2000; 45(4):291-7. PubMed ID: 10755317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioactivation of capecitabine in human liver: involvement of the cytosolic enzyme on 5'-deoxy-5-fluorocytidine formation.
    Tabata T; Katoh M; Tokudome S; Hosakawa M; Chiba K; Nakajima M; Yokoi T
    Drug Metab Dispos; 2004 Jul; 32(7):762-7. PubMed ID: 15205393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratumoral pyrimidine nucleoside phosphorylase (PyNPase) activity predicts a selective effect of adjuvant 5'-deoxy-5-fluorouridine (5'DFUR) on breast cancer.
    Hata Y; Takahashi H; Sasaki F; Ogita M; Uchino J; Yoshimoto M; Akasaka Y; Nakanishi Y; Sawada Y
    Breast Cancer; 2000 Jan; 7(1):37-41. PubMed ID: 11029769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive correlation between the efficacy of capecitabine and doxifluridine and the ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase activities in tumors in human cancer xenografts.
    Ishikawa T; Sekiguchi F; Fukase Y; Sawada N; Ishitsuka H
    Cancer Res; 1998 Feb; 58(4):685-90. PubMed ID: 9485021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral versus intravenous fluoropyrimidines for advanced colorectal cancer: by either route, it's all the same.
    Mayer RJ
    J Clin Oncol; 2001 Nov; 19(21):4093-6. PubMed ID: 11689576
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.